Searched for: subject%3A%22Therapy%255C%2Beffect%22
(1 - 6 of 6)
document
van Dommelen, P. (author), Kamphuis, M. (author), van Leerdam, F.J.M. (author), de Wilde, J.A. (author), Rijpstra, A. (author), Campagne, A.E. (author), Verkerk, P.H. (author), TNO Kwaliteit van Leven (author)
Objective: To assess the short- and long-term effects of 3 simple behavioral interventions to overcome nocturnal enuresis in young children. Study design: We performed a randomized controlled trial in children aged four to five years with mono-symptomatic nocturnal enuresis (n = 570). The children were placed in one of four groups: (1) lifting...
article 2009
document
Liu, J. (author), O'Brien, K.L. (author), Lynch, D.M. (author), Simmons, N.L. (author), La Porte, A. (author), Riggs, A.M. (author), Abbink, P. (author), Coffey, R.T. (author), Grandpre, L.E. (author), Seaman, M.S. (author), Landucci, G. (author), Forthal, D.N. (author), Montefiori, D.C. (author), Carville, A. (author), Mansfield, K.G. (author), Havenga, M.J. (author), Pau, M.G. (author), Goudsmit, J. (author), Barouch, D.H. (author), TNO Kwaliteit van Leven (author)
A recombinant adenovirus serotype 5 (rAd5) vector-based vaccine for HIV-1 has recently failed in a phase 2b efficacy study in humans. Consistent with these results, preclinical studies have demonstrated that rAd5 vectors expressing simian immunodeficiency virus (SIV) Gag failed to reduce peak or setpoint viral loads after SIV challenge of rhesus...
article 2009
document
Bekkema, N. (author), Wiefferink, C. (author), Mikolajczak, J. (author), TNO Kwaliteit van Leven (author), KvL (author)
In cooperation with its American developers, the Parent Management Training Oregon (PMTO) model was introduced into the Dutch youth care system at the beginning of 2006. In general, implementing new interventions in practice is no simple matter. Several factors related to the socio-political context, the organizational context, the intervention...
article 2008
document
Kroese, M.E.A.L. (author), Schulpen, G.J.C. (author), Sonneveld, H.M. (author), Vrijhoef, H.J.M. (author), TNO Kwaliteit van Leven (author)
Rationale: In this study, information was gathered from five disciplines on their usual management methods for fibromyalgia (FM) in order to asses whether treatment regimens have changed in the Netherlands during a period of 6 years. In addition, insight was gained into the therapeutic motives of the professionals. Method: A questionnaire was...
article 2008
document
Bergheanu, S.C. (author), Reijmers, T. (author), Zwinderman, A.H. (author), Bobeldijk, I. (author), Ramaker, R. (author), Liem, A.-H. (author), van der Greef, J. (author), Hankemeier, T. (author), Jukema, J.W. (author), TNO Kwaliteit van Leven (author)
Objective: Lipid profiling (lipidomics) may be useful in revealing detailed information with regard to the effects on lipid metabolism, the cardiovascular risk and to differentiate between therapies. The aims of the present study were to: (1) analyze in depth the lipid changes induced by rosuvastatin and atorvastatin at different dosages; (2)...
article 2008
document
Zacharowski, K. (author), Zacharowski, P.A. (author), Friedl, P. (author), Mastan, P. (author), Koch, A. (author), Boehm, O. (author), Rother, R.P. (author), Reingruber, S. (author), Henning, R. (author), Emeis, J.J. (author), Petzelbauer, P. (author), TNO Kwaliteit van Leven (author)
Many compounds have been shown to prevent reperfusion injury in various animal models, although to date, translation into clinic has revealed several obstacles. Therefore, the National Heart, Lung, and Blood Institute convened a working group to discuss reasons for such failure. As a result, the concept of adequately powered, blinded, randomized...
article 2007
Searched for: subject%3A%22Therapy%255C%2Beffect%22
(1 - 6 of 6)